Sinigrin

CAT:
804-HY-N0404-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Sinigrin - image 1

Sinigrin

  • Description:

    Sinigrin (Allyl-glucosinolate) is an orally active glucosinolate found in cruciferous plants. Sinigrin possesses multiple activities such as anti-cancer, antibacterial, antifungal, anti-inflammatory, antioxidant, and inhibition of fat synthesis. Sinigrin can be used in the research of tumors, inflammatory, and metabolic diseases[1][2][3][4].
  • Product Name Alternative:

    Allyl-glucosinolate; 2-Propenyl-glucosinolate
  • UNSPSC:

    12352005
  • Hazard Statement:

    H317
  • Target:

    Akt; AMPK; Apoptosis; Bacterial; CDK; Fungal; Interleukin Related; mTOR; p38 MAPK; PI3K; PPAR; Reactive Oxygen Species (ROS)
  • Type:

    Natural Products
  • Related Pathways:

    Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR; Vitamin D Related/Nuclear Receptor
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cancer; Infection; Metabolic Disease; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/sinigrin.html
  • Purity:

    99.97
  • Solubility:

    H2O : 25 mg/mL (ultrasonic)
  • Smiles:

    O[C@@H]1[C@@H] (O) [C@H] (S/C (CC=C) =N/OS (=O) (O[K]) =O) O[C@H] (CO) [C@H]1O
  • Molecular Formula:

    C10H16KNO9S2
  • Molecular Weight:

    397.46
  • Precautions:

    H317
  • References & Citations:

    [1]Lee HW, et al. Inhibitory effect of sinigrin on adipocyte differentiation in 3T3-L1 cells: Involvement of AMPK and MAPK pathways. Biomed Pharmacother. 2018 Jun;102:670-680.|[2]Rama Satya Sri Kotipalli, et al. Sinigrin Attenuates the Dextran Sulfate Sodium-induced Colitis in Mice by Modulating the MAPK Pathway. Inflammation. 2023 Jun;46 (3) :787-807. |[3]Li S, et al. Sinigrin Impedes the Breast Cancer Cell Growth through the Inhibition of PI3K/AKT/mTOR Phosphorylation-Mediated Cell Cycle Arrest. J Environ Pathol Toxicol Oncol. 2022;41 (3) :33-43.|[4]Mazumder A, et al. Sinigrin and Its Therapeutic Benefits. Molecules. 2016 Mar 29;21 (4) :416.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture and light)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    No Development Reported
  • Isoform:

    CDK4; CDK6; IL-1; IL-6; PPARγ
  • CAS Number:

    3952-98-5